Osmotica Pharmaceuticals plc OSMT
$ 1.08
-10.74%
Osmotica Pharmaceuticals plc Financial Statements 2011-2024 | OSMT
Annual Financial Statements Osmotica Pharmaceuticals plc
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
262 M | 355 M | 361 M | - | - | - | - | - | - | - |
Shares |
62.8 M | 52.4 M | 45.3 M | - | - | - | - | - | - | - |
Net Income |
-79.6 M | -271 M | -109 M | -45.2 M | -41.8 M | - | - | - | - | - |
Revenue |
178 M | 240 M | 264 M | 246 M | 218 M | - | - | - | - | - |
EBITDA |
22.8 M | 60.1 M | 87.3 M | 67.4 M | 21.4 M | - | - | - | - | - |
Operating Expenses |
102 M | 125 M | 123 M | 99.6 M | 95 M | - | - | - | - | - |
General and Administrative Expenses |
82 M | 93 M | 74.2 M | - | - | - | - | - | - | - |
All numbers in USD currency